Literature DB >> 21801720

The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population.

Hanen Belfki1, Samir Ben Ali, Souha Bougatef, Decy Ben Ahmed, Najet Haddad, Awatef Jmal, Monia Abdennebi, Habiba Ben Romdhane.   

Abstract

OBJECTIVE: This study was undertaken to investigate the relationship between the Apolipoprotein B/Apolipoprotein A 1 (ApoB/ApoA 1) ratio and various characteristics of the metabolic syndrome (MetS) in a sample of the Tunisian population.
METHODS: The study included 330 adults aged 35-74 (172 patients with MetS and 158 controls). Waist circumference (WC), blood pressure (BP), HDL-cholesterol (HDL-C), triglycerides (TG), glucose, insulin, and apolipoprotein concentrations were measured. Homeostasis model assessment (HOMA) was used to assess insulin resistance (IR). MetS was defined by NCEP-ATPIII report.
RESULTS: The ApoB/ApoA 1 ratio was significantly higher in patients with MetS versus normal control subjects (p<0.001). Mean values of ApoB/ApoA 1 ratio increased significantly as the numbers of MetS components increased in men (p<0.001) and women (p<0.001). ApoB/ApoA 1 ratio showed statistically significant associations with WC, HDL-C, TG, systolic and diastolic BP, and HOMA-IR. After adjusting for age and gender, the high ApoB/ApoA 1 ratio was significantly associated with the presence of MetS (odds ratio [OR]=6.10), IR (OR=1.88), and with each of the MetS components, including: high WC (OR=2.43), High TG (OR=6.14), and low HDL-C (OR=6.92).
CONCLUSIONS: Our findings suggest that the ApoB/ApoA 1 ratio is strongly associated with MetS and its components, as well as with IR.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21801720     DOI: 10.1016/j.yexmp.2011.06.007

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  5 in total

1.  Predictive value of serum apolipoprotein B/apolipoprotein A-I ratio in metabolic syndrome risk: a Chinese cohort study.

Authors:  Yu-Ching Chou; Jen-Chun Kuan; Chyi-Huey Bai; Tsan Yang; Wan-Yun Chou; Po-Chien Hsieh; San-Lin You; Lee-Ching Hwang; Chien-Hua Chen; Cheng-Yu Wei; Chien-An Sun
Journal:  Endocrine       Date:  2014-10-12       Impact factor: 3.633

2.  Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan.

Authors:  Alma Nurtazina; Dana Kozhakhmetova; Daulet Dautov; Aizhan Shakhanova; Vijay Kumar Chattu
Journal:  Diagnostics (Basel)       Date:  2020-07-23

3.  Impact of corpulence parameters and haemoglobin A1c on metabolic control in type 2 diabetic patients: comparison of apolipoprotein B/A-I ratio with fasting and postprandial conventional lipid ratios.

Authors:  Mustapha Diaf; Boumediene M Khaled; Fériel Sellam
Journal:  Libyan J Med       Date:  2015-05-08       Impact factor: 1.743

4.  The association between the apolipoprotein A1/ high density lipoprotein -cholesterol and diabetes in Taiwan - a cross-sectional study.

Authors:  Zhi-Hong Jian; Chia-Chi Lung; Pei-Chieh Ko; Yi-Hua Sun; Jing-Yang Huang; Chien-Chang Ho; Chia-Yo Ho; Yi-Chen Chiang; Chien-Jen Chen; Yung-Po Liaw
Journal:  BMC Endocr Disord       Date:  2013-10-07       Impact factor: 2.763

5.  Association of the apolipoprotein b/apolipoprotein a-I ratio, metabolic syndrome components, total cholesterol, and low-density lipoprotein cholesterol with insulin resistance in the population of georgia.

Authors:  Zaza Makaridze; Elene Giorgadze; Ketevan Asatiani
Journal:  Int J Endocrinol       Date:  2014-05-13       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.